Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
McKesson
Covington
Harvard Business School
Chubb
Fish and Richardson
Merck
Johnson and Johnson

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020056

« Back to Dashboard

NDA 020056 describes ATROPINE SULFATE, which is a drug marketed by Us Army, Akorn, Fresenius Kabi Usa, and Hospira, and is included in four NDAs. It is available from four suppliers. Additional details are available on the ATROPINE SULFATE profile page.

The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
Summary for 020056
Tradename:ATROPINE SULFATE
Applicant:Us Army
Ingredient:atropine sulfate
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL, METERED;INHALATIONStrengthEQ 0.36MG BASE/INH
Approval Date:Sep 19, 1990TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fuji
Federal Trade Commission
Cipla
Cantor Fitzgerald
Citi
Moodys
Express Scripts
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.